CALLABLE MULTI DEFENDER VONTI - ROCHE GS/LONZA GROUP/NOVARTIS N/SWISSCOM N Share Price

Certificat

RMAUIV

CH1308709604

Market Closed - Swiss Exchange 08:50:01 06/05/2024 pm IST
101 CHF +0.80% Intraday chart for CALLABLE MULTI DEFENDER VONTI - ROCHE GS/LONZA GROUP/NOVARTIS N/SWISSCOM N
Current month+0.40%
1 month-0.88%
Date Price Change Volume
06/24/06 101 +0.80% 0
02/24/02 100.2 -0.40% 0

Delayed Quote Swiss Exchange

Last update May 06, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMAUIV
ISINCH1308709604
Date issued 05/01/2024
Strike 251.3 CHF
Maturity 05/01/2026 (606 Days)
Parity 0.25 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 102.3 CHF
Lowest since issue 100.2 CHF
Spread 10 CHF
Spread %0.99%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAUIV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW